Search Results - "Lim JSJ"

NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies.

Authors: R Choo J Jeraj SN Sundar R et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Jun 09; Vol. 17, pp. 17588359251339930. Date of Electronic Publication: 2025 Jun 09 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Scalp cooling therapy for chemotherapy-induced hair loss in patients with breast or gynecological cancers-an Asian tertiary institution experience.

Authors: Lee VGH Loh J Hui F et al.

Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Nov 01; Vol. 32 (11), pp. 762. Date of Electronic Publication: 2024 Nov 01.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit.

Authors: Walsh RJ Ong R Cheo SW et al.

Source: Frontiers in oncology [Front Oncol] 2024 May 15; Vol. 14, pp. 1342346. Date of Electronic Publication: 2024 May 15 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Trastuzumab-deruxtecan in breast cancer treatment: Balancing the triad of efficacy, safety and accessibility.

Authors: Lee VGH Lim JSJ

Source: Annals of the Academy of Medicine, Singapore [Ann Acad Med Singap] 2025 Aug 27; Vol. 54 (8), pp. 455-457. Date of Electronic Publication: 2025 Aug 27.

Publication Type: Editorial

Journal Info: Publisher: Academy Of Medicine, Singapore Country of Publication: Singapore NLM ID: 7503289 Publication Model: Electronic Cited Medium: Internet ISSN: 2972-4066 (Electronic) Linking ISSN: 03044602 NLM ISO Abbreviation: Ann Acad Med Singap Subsets: MEDLINE; In Process

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.

Authors: Chee CE Ooi M Lee SC et al.

Source: Targeted oncology [Target Oncol] 2023 May; Vol. 18 (3), pp. 391-402. Date of Electronic Publication: 2023 Apr 15.

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testing.

Authors: Cheo SW Zhao JJ Ong PY et al.

Source: ESMO open [ESMO Open] 2025 Mar; Vol. 10 (3), pp. 104495. Date of Electronic Publication: 2025 Mar 10.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP).

Authors: Turner N Saura C Aftimos P et al.

Corporate Authors: Turner N Saura C Aftimos P et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Feb 10; Vol. 43 (5), pp. 513-523. Date of Electronic Publication: 2024 Oct 23.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.

Authors: Chia DKA Sundar R Kim G et al.

Source: Annals of surgical oncology [Ann Surg Oncol] 2022 Dec; Vol. 29 (13), pp. 8597-8605. Date of Electronic Publication: 2022 Sep 07.

Publication Type: Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Brief Magnetic Field Exposure Stimulates Doxorubicin Uptake into Breast Cancer Cells in Association with TRPC1 Expression: A Precision Oncology Methodology to Enhance Chemotherapeutic Outcome.

Authors: Sukumar VK Tai YK Chan CW et al.

Source: Cancers [Cancers (Basel)] 2024 Nov 18; Vol. 16 (22). Date of Electronic Publication: 2024 Nov 18.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors.

Authors: Choo JRE Jan YH Ow SGW et al.

Source: Targeted oncology [Target Oncol] 2022 May; Vol. 17 (3), pp. 355-368. Date of Electronic Publication: 2022 Jun 14.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors.

Authors: Lee MX Wong ALA Ow S et al.

Source: Targeted oncology [Target Oncol] 2022 Mar; Vol. 17 (2), pp. 141-151. Date of Electronic Publication: 2022 Feb 23.

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.

Authors: Ang YLE Ho GF Soo RA et al.

Source: BMC cancer [BMC Cancer] 2020 Nov 17; Vol. 20 (1), pp. 1118. Date of Electronic Publication: 2020 Nov 17.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Maintaining breast cancer care in the face of COVID-19.

Authors: Ng CWQ Tseng M Lim JSJ et al.

Source: The British journal of surgery [Br J Surg] 2020 Sep; Vol. 107 (10), pp. 1245-1249.

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press on behalf of BJS Foundation Ltd Country of Publication: England NLM ID: 0372553 Publication Model: Print Cited Medium: Internet ISSN: 1365-2168 (Electronic) Linking ISSN: 00071323 NLM ISO Abbreviation: Br J Surg Subsets: MEDLINE

Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy.

Authors: Bandla A Tan S Kumarakulasinghe NB et al.

Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2020 Aug; Vol. 28 (8), pp. 3691-3699. Date of Electronic Publication: 2019 Dec 06.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines.

Authors: Lim JSJ Ow SGW Wong ALA et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Nov; Vol. 193, pp. 113311. Date of Electronic Publication: 2023 Aug 25.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Efficacy of Oral SERDs in the treatment of ER+, HER2 - metastatic breast cancer, a stratified analysis of the ESR1 wild type and mutant subgroups.

Authors: Wong NZH Yap DWT Ong RJM et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Oct 21. Date of Electronic Publication: 2023 Oct 21.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer.

Authors: Zhao JJ Fong KY Chan YH et al.

Source: Cancers [Cancers (Basel)] 2023 Sep 14; Vol. 15 (18). Date of Electronic Publication: 2023 Sep 14.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort Study.

Authors: Tan WC Tan JYJ Lim JSJ et al.

Source: JAMA oncology [JAMA Oncol] 2023 Sep 01; Vol. 9 (9), pp. 1221-1229.

Publication Type: Observational Study; Multicenter Study; Journal Article

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma.

Authors: Kong LR Mohamed Salleh NAB Ong RW et al.

Source: Nature communications [Nat Commun] 2020 Mar 25; Vol. 11 (1), pp. 1556. Date of Electronic Publication: 2020 Mar 25.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Immune checkpoint inhibitor combinations-current and emerging strategies.

Authors: Walsh RJ Sundar R Lim JSJ

Source: British journal of cancer [Br J Cancer] 2023 Apr; Vol. 128 (8), pp. 1415-1417. Date of Electronic Publication: 2023 Feb 06.

Publication Type: Editorial

Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE